Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.56)
# 1597
Out of 5,358 analysts
110
Total ratings
34.33%
Success rate
20.62%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SENS Senseonics Holdings | Assumes: Buy | 2 | 0.53 | 107.55% | 1 | Jun 2, 2025 | |
CASI CASI Pharmaceuticals | Reiterates: Buy | 4 4 | 1.86 | 115.05% | 9 | May 19, 2025 | |
CTSO CytoSorbents | Reiterates: Neutral | 1 1 | 1.05 | -4.76% | 13 | May 15, 2025 | |
VSTM Verastem | Maintains: Strong Buy | 10 14 | 6.42 | 118.07% | 14 | May 9, 2025 | |
DWTX Dogwood Therapeutics | Upgrades: Buy | 10 | 4.73 | 111.42% | 1 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 12.72 | 57.23% | 12 | Apr 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 37.95 | 5.4% | 10 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 0.33 | 1566.67% | 11 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 3.92 | 180.61% | 3 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 10 | 2.96 | 220.95% | 5 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 5.59 | 1688.91% | 4 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.28 | 2243.75% | 1 | Dec 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |